Untangling the CRISPR cancer scare
New CRISPR genome-editing system can target disease-causing genetic variations – Harvard Gazette
Precision CRISPR system averts hearing loss in mice - Boston Children's Discoveries
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
Kill Switch for CRISPR Could Make Gene Editing Safer - Scientific American
CRISPR, the disruptor : Nature News & Comment
CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review
Nature journal retracts controversial CRISPR paper after authors admit results may be wrong – Retraction Watch
CRISPR gene editing - Wikipedia
Four U.S. CRISPR Trials Editing Human DNA to Research New Treatments | Science | Smithsonian Magazine
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research: Molecular Therapy - Methods & Clinical Development
First CRISPR editing trial results assuage safety concerns
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy | Nature Medicine
Focus on CRISPR tools and therapies | Nature Biotechnology
Development of a CRISPR/Cas9-based therapy for Hutchinson–Gilford progeria syndrome | Request PDF
Nature Medicine on Twitter: "Two studies find that #AAV-mediated #CRISPR/ Cas9 therapy extends life span and ameliorates disease-related phenotypes in a mouse model of #progeria. https://t.co/2LfOogSXLX and https://t.co/y5KjuD5Yjb… https://t.co/RMaa25wQoI"
CRISPR, the disruptor : Nature News & Comment
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine
First Trial of CRISPR-Edited T cells in Lung Cancer: Trends in Molecular Medicine
PDF) The CRISPR tool kit for genome editing and beyond
Developing CRISPR/CAS9 technologies for research and medicine - MedCrave online
:no_upscale()/cdn.vox-cdn.com/uploads/chorus_image/image/60457727/CRISPR_LEAD.0.jpg "CRISPR, one of the biggest science stories of the decade, explained - Vox")
CRISPR, one of the biggest science stories of the decade, explained - Vox
CRISPR-engineered T cells in patients with refractory cancer | Science
A CRISPR Approach to Treating Sickle Cell – NIH Director's Blog
Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. - Nat. Med. - X-MOL
A new research revealed that the CRISPR–Cas9 genome editing technique may increase cancer risk - Biotech Advisers
